Protai

Protai is an AI-driven drug discovery company targeting hard-to-drug protein complexes, by combining structural proteomics with computational predictions.

  • Pipeline: Best-in-class small molecules in oncology and I&I; lead KAT6A degrader entering clinic late 2026
  • Platform: AIMS™ platform enabling end-to-end drug discovery for biopharma across indications

Address

Tel Aviv
Israel
Loading